USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
07 Feb 2023 | 03:45 PM GMT

Product Differentiation for Digital Health Solutions in the Cardiometabolic Disease Area

Anchored by:

Jenn Roberts
VP, Employer Health Strategy
HELLO HEART

Participants:

Jenn Roberts VP, Employer Health StrategyHello Heart
Jenn Roberts
VP, Employer Health StrategyHello Heart
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Fulvio Michelis Digital Strategy DirectorMerck KGaA
Fulvio Michelis
Digital Strategy DirectorMerck KGaA
Jon Melnick Engagement ManagerZS Associates
Jon Melnick
Engagement ManagerZS Associates
Kelly Blaszczak Senior Director of MarketingWelth
Kelly Blaszczak
Senior Director of MarketingWelth
Sandra Nagale Director, AI Partnerships & Digital HealthBoston Scientific
Sandra Nagale
Director, AI Partnerships & Digital HealthBoston Scientific

About this Meeting

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

In the past few years, digital health solutions have proven to be helpful in preventing and managing cardiometabolic diseases remotely, leading to better health outcomes and less hospitalizations, emergency visits, and in-office visits. In light of the positive impact in health outcomes and the size of the patient population, we have seen many innovators venturing into the cardiometabolic space, leading to a market saturation. With so many other competitors in this field, how can digital health companies differentiate their products and become top-of-mind for their customers? Join this session to discuss with your peers:
  • Building brand loyalty: how to make your brand a differentiator? Basic products with a strong brand are often more successful than specialised solutions with a weak brand. How can digital health companies use the brand as a differentiator? What are the keys to build a brand that resonates with cardiometabolic patients?
  • Communicating effectively. How can digital health companies identify the product qualities that make them different and more valuable both for their end client (patient) and the ‘middle man’ (i.e. physician, health systems, payers, etc.)? How can they optimise and tailor their narrative to maximise impact?
  • Focus on niche targets vs. the wide patient population. How can innovators use the niche target strategy in the cardiometabolic space to differentiate from the crowd (e.g. stroke patients from 35 to 50)?
  • Specialised companies vs. consumer-based companies (the likes of Apple, Fitbit, etc). Whilst they are not as specialised as digital health startups, companies like Apple have a large consumer base and a powerful brand. How can smaller companies compete and differentiate?
  • How to leverage the human factor to stand out from the crowd. We have recently seen digital health platforms incorporating the human touch, by offering more coaching services to patients. Is this a good avenue for startups in the cardiometabolic space?  
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.